Shanghai Shenqi Medical Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Shanghai Shenqi Medical Technology Co., Ltd. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include SWIDE, SHENQI, and SHENQI MEDICAL.
Room 601, Building 8,
200 Niudun Road, China (Shanghai) PilotF
Showing of trademarks Trademarks
Trademark Classifications
Shanghai Shenqi Medical Technology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Shanghai Shenqi Medical Technology Co., Ltd. have?
Shanghai Shenqi Medical Technology Co., Ltd. has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Shanghai Shenqi Medical Technology Co., Ltd. file in?
Shanghai Shenqi Medical Technology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Shanghai Shenqi Medical Technology Co., Ltd.'s most well-known trademarks?
Shanghai Shenqi Medical Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as SWIDE, SHENQI, and SHENQI MEDICAL. These are among 6 currently registered trademarks in the portfolio.
What is Shanghai Shenqi Medical Technology Co., Ltd.'s trademark registration success rate?
Shanghai Shenqi Medical Technology Co., Ltd. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.